What question did this study set out to answer?

This study aims to uncover the mechanisms through which traditional Chinese medicine affects postmenopausal osteoporosis.

May 14, 2026

Integrating Multi-omics, Mendelian Randomization, and ExperimentalValidation to Unveil the Role of Traditional Chinese Medicine inPostmenopausal Osteoporosis

Key Points

This study aims to uncover the mechanisms through which traditional Chinese medicine affects postmenopausal osteoporosis.
Analyzed bulk transcriptome and single-cell RNA sequencing data using various bioinformatics approaches.
Utilized Mendelian randomization with the TwoSampleMR package to establish causal relationships.
Performed molecular docking to validate drug-target interactions involving CTNNB1.
Identified five critical genes associated with PMOP, with AUC values above 0.7, suggesting their importance in disease progression.
Mendelian randomization showed a causal relationship between CTNNB1 and osteoporosis (OR=0.950, P=6.45E-17).
Animal PCR results confirmed the expression of CTNNB1, highlighting its role in the therapeutic effects of TCM.

Abstract

Introduction: Postmenopausal Osteoporosis (PMOP) is an age-related disease prevalent among elderly women, characterized by decreased bone density and increased fracture risk. This study investigates the mechanisms of traditional Chinese medicine (TCM) in treating PMOP. Methods: We analyzed bulk transcriptome data (GSE56815) and scRNA-seq data (GSE169396) using a range of bioinformatics techniques, including WGCNA, co-expression analysis, proteinprotein interaction (PPI) analysis, and immune infiltration. Transcription factor interactions and protein pathway involvement were explored. The TwoSampleMR package and SMR database were utilized for Mendelian randomization analysis. Molecular docking was performed using beta-carotene from Eucommia ulmoides Oliv as a ligand and CTNNB1 as a receptor to validate drug-target binding. Results and Discussion: The study identified five key genes (PPP3CA, CTNNB1, NCOA2, NPEPPS, and ADRB) with AUC values above 0.7, which are involved in critical cellular and immune processes related to PMOP. Immune infiltration analysis emphasized the role of Tregs and correlated specific genes with various immune cells. Key transcription factors, including ELK1, SREBF1, PRRX2, FOXC1, and FOXL1, were identified as regulators of CTNNB1. Single- cell analysis revealed CTNNB1's predominant distribution in osteoclastic cells. Mendelian randomization analysis demonstrated a causal relationship between CTNNB1 and osteoporosis (OR=0.950431762, P =6.45E-17). Additionally, animal PCR results validated the expression of the key gene CTNNB1. These results suggest that CTNNB1 related pathways may play a role in the therapeutic effects of traditional Chinese medicine in PMOP. Conclusion: Our study sheds light on five critical targets related to PMOP progression. We found that TCM potentially modulates the miR-139-3p/ELK1/CTNNB1 axis within the noncanonical Wnt pathway, impacting osteoblast differentiation and providing therapeutic benefits for PMOP.

Perguntar à IA

Bookmark

Cite This Study

Xiao et al. (Fri,) studied this question.

synapsesocial.com/papers/6a0566d9a550a87e60a1ec47 https://doi.org/https://doi.org/10.2174/0115734099401120251101190026

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Perguntar à IA

Bookmark